$4.15
8.99% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$4.15
-2.81 40.37% 1M
-3.12 42.92% 6M
-2.55 38.06% YTD
-1.13 21.40% 1Y
-35.89 89.64% 3Y
-28.85 87.42% 5Y
-28.85 87.42% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.41 8.99%
ISIN
US38246G1085
Symbol
GDRX

Key metrics

Market capitalization $1.58b
Enterprise Value $1.70b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 11.09
EV/Sales (TTM) EV/Sales 2.15
P/S ratio (TTM) P/S ratio 2.00
P/B ratio (TTM) P/B ratio 2.27
Revenue growth (TTM) Revenue growth 7.14%
Revenue (TTM) Revenue $790.39m
EBIT (operating result TTM) EBIT $46.07m
Free Cash Flow (TTM) Free Cash Flow $153.53m
Cash position $423.78m
EPS (TTM) EPS $-0.04
P/E forward 72.22
P/S forward 2.16
EV/Sales forward 2.31
Short interest 9.31%
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a GoodRx Holdings forecast:

11x Buy
58%
7x Hold
37%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a GoodRx Holdings forecast:

Buy
58%
Hold
37%
Sell
5%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
790 790
7% 7%
100%
- Direct Costs 144 144
13% 13%
18%
646 646
6% 6%
82%
- Selling and Administrative Expenses 382 382
2% 2%
48%
- Research and Development Expense 124 124
6% 6%
16%
141 141
34% 34%
18%
- Depreciation and Amortization 95 95
46% 46%
12%
EBIT (Operating Income) EBIT 46 46
14% 14%
6%
Net Profit -16 -16
208% 208%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
PRNewsWire
2 days ago
NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx Holdings, Inc. (NASDAQ: GDRX)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, GoodRx insiders caused the company to misrepresent or fail to disclose that (1) while Kroger accounted for less th...
Neutral
Business Wire
3 days ago
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an innovative initiative to expand access and affordability for its ophthalmic pharmaceutical products. This effort includes a program of targeted price reductions for several Harrow products and a strategic partnership with GoodRx (Nasdaq: GDRX), the lead...
Neutral
GlobeNewsWire
3 days ago
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX) on behalf of long-term stockholders following a class action complaint that was filed against GoodRx on April 22, 2024 with a Class Period from September 23, 2020, to November 8, 2022. Our inv...
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Scott Wagner
Employees 694
Founded 2015
Website www.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today